Hot Performing Stocks To Watch For 2014

Gold prices plunged over the past three months, making it almost impossible to find a money-making trade in the precious-metals sector during the second quarter. But by using exchange-traded products designed for short-term traders, those courageous enough to ride the wave downward in gold and silver prices were richly rewarded with huge gains. Let's take a closer look at these investments with an eye toward deciding if they make sense for those with a longer-term perspective.

The perfect time for precious-metals leverage
The best-performing exchange-traded products in the market were those that bet against gold and silver bullion and mining companies. In particular, VelocityShares 3x Inverse Silver ETN (NYSEMKT: DSLV  ) managed to rise 140% over the past three months, while the similar inverse gold ETN posted more modest gains of about 90%. Bets against mining stocks were equally lucrative, with the popular Direxion Daily Gold Miners Bear 3x (NYSEMKT: DUST  ) coming close to matching the inverse silver ETN's performance at a nearly 140% rise.

Top 5 Life Sciences Companies To Buy Right Now: inContact Inc.(SAAS)

inContact, Inc. provides cloud-based contact center software services and network connectivity in the United States. Its solutions include inContact ACD, an automatic call distributor; inContact CTI, a computer telephony integration that integrates with customer data servers to provide agents pre-populated customer data; inContact IVR, an interactive voice response solution to create specialized call flows; and inContact Integrations for integration of various hardware and software solutions already in place at customer sites. The company also offers inContact ECHO that gathers the opinion of the customer and presents the analysis of the feedback directly to supervisors and agents; inContact Workforce Management, which forecasts demand, schedules workforce, analyzes and optimizes staffing, and reports real-time adherence in contact centers; inContact Quality Monitoring that provides insights into agent performance and customer satisfaction; and InContact Screen Recording, which provides compliance level screen recording functionality for voice channel interactions. In addition, it provides inContact eLearning that offers targeted, prioritized training, communications, and testing to the agent?s desktop during dips in call volumes; and inContact Network Connectivity, which includes time division multiplexing and voice over Internet protocol (VoIP) connectivity, and toll-free and local-number services. Further, inContact, Inc. offers professional services, as well as operates as a domestic and international long distance reseller and aggregator. The company was formerly known as UCN, Inc. and changed its name to inContact, Inc. in January 2009. inContact, Inc. was founded in 1994 and is headquartered in Salt Lake City, Utah.

Advisors' Opinion:

• [By John Udovich]

  Small cap cloud contact software provider Five9 Inc (NASDAQ: FIVN) saw a small pop when it debuted in an IPO last Friday but its now trended back down to its debut price, meaning its worth taking a closer look at the stock along with some potential peers or benchmarks like Incontact Inc (NASDAQ: SAAS), eGain Corp (NASDAQ: EGAN) and LivePerson, Inc (NASDAQ: LPSN).

• [By Steve Symington]

  What:�Shares of inContact Inc. (NASDAQ: SAAS  ) rose more than 10% in Wednesday's early trading, and then gave back most of those gains to close up around 1% after the cloud contact center software provider released first-quarter results and announced an acquisition.

Hot Performing Stocks To Watch For 2014: Pazoo Inc (PZOO)

Pazoo, Inc., formerly IUCSS, Inc., incorporated on November 16, 2010, is a development-stage company. The Company is an online retailer and distributer of nutritional foods/supplements, wellness goods, and fitness apparel.

As of December 31, 2011, the Company�� source of revenue was through www.pazoo.com. The Company offers a range of products through various catalogs, such as health and beauty, vitamins and supplements, apparel, accessories, food and beverages, fitness and sports equipments, gifts, videos and books, and pet wellness.

Advisors' Opinion:

• [By Bryan Murphy]

  For those traders who were lucky and smart enough to be in an Arotech Corporation (NASDAQ:ARTX) before today, then congratulations - you're up at least 38% on your position. Now it's time to get out. Conversely, if you're looking for a new name to get into (or perhaps looking for a place to park your ARTX proceeds), then you may want to consider Pazoo Inc. (OTCBB:PZOO)... a tiny online retailer of health and fitness goods. PZOO has dropped several tell-tale hints that more upside is on the way.

Hot Performing Stocks To Watch For 2014: Medallion Financial Corp.(TAXI)

Medallion Financial Corp., through its subsidiaries, operates as a specialty finance company in the United States. The company engages in originating, acquiring, and servicing loans that finance taxicab medallions and various types of commercial businesses. It offers commercial loans to finance the purchase of the equipment and related assets necessary to open a new business, or the purchase or improvement of an existing business; asset-based loans to small businesses; and secured mezzanine loans to businesses in various industries, including manufacturing and various service providers. The company also raises deposits; originates consumer loans for the purchase of recreational vehicles, boats, motorcycles, trailers, and hearing aids; and conducts other banking activities. In addition, it provides other debt, mezzanine, and equity investment capital to companies in various industries. The company was founded in 1995 and is headquartered in New York, New York.

Advisors' Opinion:

• [By Lawrence Meyers]

  That�� the case with Medallion Financial Corporation (TAXI). This neat little company is primarily focused on the financing of taxi cab licenses in major cities like New York. It does other specialty lending as well — such as asset-backed loans for luxury vehicles like boats and art. But its bread and butter has been the taxi business.

Hot Performing Stocks To Watch For 2014: Halozyme Therapeutics Inc.(HALO)

Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of recombinant human enzymes that transiently modify tissue under the skin to facilitate injection of other therapies or correct diseased tissue structures for clinical benefits. The company primarily offers recombinant human hyaluronidase, an enzyme that degrades hyaluronan, which is a matrix component in the skin, and facilitates the dispersion and absorption of drugs and fluids. Its portfolio of products and product candidates are developed based principally on intellectual property covering the family of human enzymes known as hyaluronidases. The company also provides Ultrafast Insulin program, a Phase II clinical trial product for the treatment of diabetes mellitus; and Enhanze technology, a proprietary drug delivery platform for subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as sma ll molecules and fluids. It offers PEGPH20, a new molecular entity that is in Phase I trial for the systemic treatment of tumors; and HTI-501, a recombinant human proteinase, which is in Phase 1/2 clinical trial used for the treatment of edematous fibrosclerotic panniculopathy (cellulite). The company has collaborative partnerships with F. Hoffmann-La Roche, Ltd and Hoffmann-La Roche, Inc.; ViroPharma Incorporated; and Intrexon Corporation to apply Enhanze technology to the partners? biological therapeutic compounds. Halozyme Therapeutics, Inc. was founded in 1998 and is based in San Diego, California.

Advisors' Opinion:

• [By Jayson Derrick]

  Halozyme Therapeutics (NASDAQ: HALO) halted patient enrollment and dosing in its Phase 2 clinical trial of PEGPH20 based on a recommendation by the Data Monitoring Committee who argued that there may be a difference in the thomboembolic rate between the PEGPH20 patients and the non-treated group. Shares lost 27.26 percent, closing at $8.43.

• [By Anna Prior]

  J.P. Morgan (JPM) initiated coverage of Halozyme Therapeutics Inc.(HALO) with an overweight rating and a $13 price target, saying in a note to clients that the company’s proprietary pipeline appears to be garnering increased attention. Halozyme shares climbed 5.2% to $9.77 premarket.

• [By Jake L'Ecuyer]

  Shares of Halozyme Therapeutics (NASDAQ: HALO) got a boost, shooting up 6.11 percent to $12.85 after the company reported that Consistent 1 trial Of Hylenex(R) recombinant has met primary endpoint.

• [By Jake L'Ecuyer]

  Equities Trading DOWN
  Shares of Halozyme Therapeutics (NASDAQ: HALO) were down 25.40 percent to $8.65 after the company announced the temporary halt of Phase 2 trial enrollment.

Hot Performing Stocks To Watch For 2014: Westfield Group (WEFIF)

Westfield Group is engaged in ownership, development, design, construction, funds/asset management, leasing and marketing activities undertaken with respect to its global portfolio of retail properties. Property investments segment includes net property income from existing shopping centers and completed developments, revaluation of existing centers and other operational expenses. Property and project management segment includes income from third parties, property management and development fees, and associated business expenses. The development segment includes revaluation of redevelopments and development projects. The corporate business unit includes unallocated corporate entity expenses. In November 2013, Starwood Capital Group LLC acquired a majority interest in seven regional malls in the United States from the Westfield Group. Advisors' Opinion:

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- Australian stocks fell early Wednesday, tracking a weak lead from the U.S. but with a few blue-chip miners higher after gains for some commodities overnight. The S&P/ASX 200 (AU:XJO) retreated 0.4% to 5,237.80 after similar losses for the main Wall Street indexes, with the Australian benchmark trading around its lowest level since October. Among the major decliners, Qantas Airways Ltd. (AU:QAN) (QUBSF) lost 2.5%, Harvey Norman Holdings Ltd. (AU:HVN) (HNORY) gave up 1.3%, and Incitec Pivot Ltd. (AU:IPL) (ICPVY) fell 1.8%. Santos Ltd. (AU:STO) (STOSF) fell 2.6% on indication it will miss its lowered production guidance for 2013, according to the Australian Financial Review. On the upside, top miners BHP Billiton Ltd. (AU:BHP) (BHP) and Rio Tinto Ltd. (AU:RIO) (RIO) rose 0.3% and 0.7%, respectively, while Fortescue Metals Group Ltd. (AU:FMG) (FSUMF) traded 1% higher. Shares of global shopping-mall developer Westfield Group Australia (AU:WDC) (WEFIF) were on halt

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- Australia stocks tilted lower early Monday as the Sydney markets reacted to last week's disappointing jobs numbers out of the U.S., with the S&P/ASX 200 (AU:XJO) down 0.2% at 5,304.40. Data out Friday showed the U.S. added a net 74,000 jobs, trailing a forecast for 193,000 positions, and while Wall Street ended mixed following the numbers, Australian stocks will global exposure moved lower. Financial major Macquarie Group Ltd. (AU:MQG) (MCQEF) fell 1.8%, mall developer Westfield Group Australia (AU:WDC) (WEFIF) retreated 0.6%, and media firm News Corp. (AU:NWS) (NWS) -- the parent of MarketWatch, publisher of this report -- gave up 1.3%. But the jobs report also depressed the U.S. dollar, which helped boost prices for dollar-denominated commodities, and this in turn supported Australian resource shares. BHP Billiton Ltd. (AU:BHP) (BHP) gained 0.6%, Rio Tinto Ltd. (AU:RIO) (RIO) added 0.9%, Alumina Ltd. (AU:AWC) (AWCMF) rallied 4.5%, and Fortescue Metals Group Ltd. (AU:FMG) (FSUMF) improved by 1.2%. A strong showing for Comex gold on Friday also sent Newcrest Mining Ltd.

Hot Performing Stocks To Watch For 2014: International Montoro Resources Inc (IMT)

International Montoro Resources Inc. is engaged in the exploration and development of mineral properties, focusing on projects in British Columbia, Saskatchewan, and Ontario, Canada. The Company holds a 100% interest in the Malachite Project (New Brunswick). The Company holds a 50% interest in the Red Lake Project (Ontario), the Malachite property consists of 62 claim units comprising 1,352.25 hacteres. The Crackingstone River Project (Saskatchewan) consists of 750 hectare claim block in northern Saskatchewan near Uranium City. The Cup Lake/Donen Claims located in the Greenwood Mining District of B.C. On May 24, 2012, the Company acquired a 100% interest in four mineral claims representing 1,065.10 hactares, which were located in the middle of the west side of the Tacheeda Lake claim block. Advisors' Opinion:

• [By Namitha Jagadeesh]

  British American Tobacco Plc and Imperial Tobacco Group Plc (IMT) each lost at least 1.5 percent as American peer Philip Morris International Inc. forecast 2014 profit growth below its long-term target. Antofagasta Plc (ANTO) and Vedanta Resources Plc (VED) followed miners lower, sliding at least 2 percent. Johnson Matthey Plc (JMAT) gained 3.9 percent after posting better-than-forecast profit and raising its dividend.

Hot Performing Stocks To Watch For 2014: Inca Minerals Ltd (ICG)

Inca Minerals Limited, formerly Condor Metals Limited, is an Australia-based exploration company. During the fiscal year ended June 30, 2011 (fiscal 2011), the Company's principal activities were conducting exploration and evaluation work on its existing tenements, as well as seeking out additional tenements. It focuses on nickel, iron, manganese and base metals exploration in Australia. During fiscal 2011, it concentrated on the Kallona iron and manganese prospect in the East Pilbar, where the first drilling was commenced in June 2011. Results received confirmed the presence of manganese, along with consistent iron intersections. The Company also continued to explore on the Dingo Range tenements south east of Wiluna. Advisors' Opinion:

• [By Fede Zaldua]

  For its third quarter, Citi reported net earnings of $3.2 billion or Earnings Per Share (EPS) of $1, which was just below consensus expectations of $1.02 per share. The bank explained its poor performance through lower than expected earnings at the Institutional Clients Group (ICG) division (mainly trading activities in equities, commodities and fixed income) but also lower Consumer Banking revenues on weaker mortgage results. Its extremely relevant to stress that third quarter ICG and mortgage related results came weaker than expected at most banking institutions, including JP Morgan (JPM) and almighty Goldman Sachs (GS). On my opinion, much more relevant metrics (because they can be more directly affected by management's decisions) such as those metrics related to expenses and credit quality came in line with expectations.